- Grants since 2016
- 279
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 1 976
- Funded works, all time
- 5 201
Grants
2024 · research · PCF Young Investigator Award
Establishing an Indication for Pyruvate Kinase Activator Therapy in Prostate Cancer
Daniel Schmidt · Harvard: Beth Israel Deaconess Medical Center
2024 · research · PCF Challenge Award
Quantitative MRI to Guide Targeted Radiotherapy for Aggressive, Pre-Metastatic Prostate Cancer
Tyler Seibert · University of Michigan
2024 · research · PCF Young Investigator Award
Using Machine Learning to Predict RNA Pol II Interactions of Metastatic Prostate Cancer
Ahmed Abbas Elmahdi · The University of Texas Southwestern Medical Center
2024 · research · PCF Young Investigator Award
Uncover the Molecular Impact of Structural Variants that Drive Castration-Resistant Prostate Cancer Using Patient-Derived Models
Chennan Li · National Cancer Institute
2024 · research · PCF Young Investigator Award
Improving Germline Testing Among Veterans with Localized High-Risk or Very High-Risk Prostate Cancer
Daniel Lee · Corporal Michael J. Crescenz Va Medical Center / University Of Pennsylvania
2024 · research · PCF Young Investigator Award
A Theranostic Approach: Targeted Alpha Therapy of Delta-Like Ligand 3 Expressing Neuroendocrine Prostate Cancer
Salomon Tendler · Memorial Sloan Kettering Cancer Center
2024 · research · PCF Young Investigator Award
ProsGATE: Geriatric Assessment and Technology Evaluation in Prostate Cancer
Nabiel Mir · University of Chicago
2024 · research · PCF Challenge Award
Targeting Metabolic Drivers of Liver Metastatic Castration Resistant Prostate Cancer
Andrew Goldstein · National Cancer Institute
2023 · research · PCF Young Investigator Award
A Novel CBP/p300 PROTAC Degrader Suppresses Prostate Cancer Progression via Re-Shaping the Chromatin Landscape and Acetylome
Jie Luo · University of Michigan
2023 · research · PCF Young Investigator Award
Optimal Methods for Identifying and Communicating which Treatments are Best for which People with Metastatic Hormone-Sensitive Prostate Cancer
Peter Godolphin · University College London
2023 · research · PCF Young Investigator Award
Impact of Androgen Receptor Signaling Inhibitors on Depression and Anxiety in Veterans with Metastatic Hormone-Sensitive Prostate Cancer
Phoebe Tsao
2023 · research · PCF Challenge Award
A Phase 2 Randomized Study of YONSA® (Abiraterone Acetate), Enzalutamide or Apalutamide as First Line Therapy in Veterans with Castrate-Sensitive Prostate Cancer
Antonio Tito Fojo · James J. Peters VA Medical Center
2023 · research · PCF Young Investigator Award
Investigating Tumor and Immune Cell Dysregulation for the Treatment of Prostate Cancer Bone Metastases
Shenglin Mei · Harvard: Massachusetts General Hospital (mgh)
2023 · research · PCF Young Investigator Award
Epigenetic and Metabolomic Vulnerabilities in ASCL1-Driven NEPC Subtype
Shaghayegh Nouruzi · University of British Columbia
2023 · research · PCF Challenge Award
Intercepting the Cancer Endocycle to Cure Lethal Prostate Cancer
Kenneth Pienta · Johns Hopkins University
2023 · research · PCF Challenge Award
A Pilot Presurgical Trial of REGN5678 (Anti-PSMAxCD28) In Patients with High-Risk, Localized Prostate Cancer Followed by Radical Prostatectomy
Padmanee Sharma · The University of Texas MD Anderson Cancer Center
2023 · research · PCF Challenge Award
Identification of Patients at High-Risk of Metastatic Disease after Neoadjuvant Intensive Androgen Signaling Inhibition
Mary-Ellen Taplin · Cedars-Sinai Medical Center
2023 · research · PCF Challenge Award
Development of a CBP/p300 Degrader for the Treatment of Castra-tion-Resistant Prostate Cancer
Arul Chinnaiyan · University of Michigan
2023 · research · PCF Challenge Award
Personalizing Treatment Decisions Through Composite Next Generation Imaging and Liquid Biomarker Development Within a Phase II Randomised Trial of Enzalutamide (+/-177Lu-PSMA-617) (ENZAp)
Louise Emmett · Johns Hopkins University
2023 · research · PCF Challenge Award
ctDNA Determinants of Resistance to 177Lu-PSMA-617 versus Taxane-Based Chemotherapy
Alexander Wyatt · Monash University
2023 · research · PCF Young Investigator Award
Artificial Intelligence-Based Lesion Kinetics Assessment for the Selection of Therapeutic Targets for Focal SBRT in Patients with Oligoprogressive Metastatic Castration Resistant (mCRPC) and Biochemically Recurrent (BCR) Prostate Cancer
Krishnan Patel · National Cancer Institute
2023 · research · PCF Young Investigator Award
Molecular Correlates with Prostate-Specific Membrane Antigen (PSMA) in Prostate Cancer
Adam Weiner · University of California, Los Angeles
2023 · research · PCF Challenge Award
Germline Influence on Prostate Cancer Metastasis and Response to Androgen Deprivation Therapy
Tyler Seibert · Veracyte (United States)
2023 · research · PCF Challenge Award
Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance in Metastatic Prostate Cancer
Karen Sfanos · Johns Hopkins University
2023 · research · PCF Challenge Award
Modulation of Anti-Androgen Response by NSD2 in Castration-Resistant Prostate Cancer
Michael Shen · Institute of Cancer Research
2023 · research · PCF Young Investigator Award
Validation and Integration of Optimized Risk Stratification and Novel Biomarkers for the Personalization of Prostate Cancer Treatment
Soumyajit Roy · Rush University Medical Center
2023 · research · PCF Challenge Award
Identifying Drivers of Aggressive Prostate Cancer and Racial Disparities in Patients Presenting with Low-Grade Disease
Vanessa Hayes · University of Illinois Chicago
2023 · research · PCF Young Investigator Award
Optimizing Outcomes in Survivors of Prostate Cancer with Diabetes
Amanda Leiter · Icahn School of Medicine at Mount Sinai
2023 · research · PCF Young Investigator Award
N-Acetyl Aspartate Sustains Castration Resistant Prostate Cancer through Glucocorticoid Induced Sphingolipid Metabolism
Mark Salji · University Of Glasgow – Cancer Research Uk Beatson Institute
2023 · research · PCF Young Investigator Award
Modulation of Oxidative Stress Responses to Augment Prostate Cancer Radiation Therapy
Katherine Morel · The University of Adelaide
2023 · research · PCF Young Investigator Award
Non-Invasive Prediction of Tumor Phenotypes, Therapeutic Targets, and Treatment Response in CRPC using ctDNA
Robert Patton · Fred Hutch Cancer Center
2023 · research · PCF Young Investigator Award
Conditionally Activated Membrane Binding Probes for Improved Targeted Radiotherapy in Metastatic Castration Resistant Prostate Cancer
Apurva Pandey · University of California, San Francisco
2023 · research · PCF Challenge Award
Metabolic Imaging and Targeted Radionuclide Combination Treatment of Prostate Cancer Bone Metastases
Edward O’Neill · University of Oxford
2023 · research · PCF Young Investigator Award
MMUVE Prostate Cancer: Multi-Omic Evaluation of Micro-Ultrasound VisiblE Prostate Cancer
Wayne Brisbane · University of California, Los Angeles
2023 · research · PCF Challenge Award
Characterizing Imaging, Genomic and Immune Predictors of 177Lu-PSMA (Lu-PSMA) and Olaparib Response in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Shahneen Sandhu · Peter MacCallum Cancer Centre
2023 · research · PCF Young Investigator Award
Breaking Barriers in Prostate Cancer: Novel Clinical Uses of PSMA Radioligand Therapy and Imaging with PSMA PET/CT
James Buteau · The University of Melbourne
2023 · research · PCF Challenge Award
Targeting Neuroendocrine Cells in Prostate Cancer with Small Molecule and Targeted Radionuclide Therapies
Andrew Armstrong · Duke University
2023 · research · PCF Young Investigator Award
Development of a Novel Molecular-Based Treatment Strategy for De Novo Metastatic Castration-Sensitive Prostate Cancer using Long-Read Transcriptome Sequencing
Takayuki Sumiyoshi · Kyoto University
2023 · research · PCF Young Investigator Award
Defining Modifiable Components of the Immune Microenvironment in Patients with Prostate Cancer Nodal Metastases
Christopher Gaffney · Memorial Sloan Kettering Cancer Center
2023 · research · PCF Young Investigator Award
Investigating how Prostate Cancer causes Sclerotic Metastatic Bone Lesions and Impact Fracture Risk using Cellular and Materials Sciences Approaches
Felipe Eltit Guersetti · University of British Columbia